Picture of BioSino Bio-technology and Science logo

8247 BioSino Bio-technology and Science Cashflow Statement

0.000.00%
hk flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapValue Trap

Annual cashflow statement for BioSino Bio-technology and Science, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

2017
December 31st
2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
HKAS
HKAS
HKAS
HKAS
HKAS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line24.8-14.5-1152.156.41
Depreciation
Amortisation
Non-Cash Items-9.6313.1129-10.122
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-28.2-18.8-16.5-6.01-7.41
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Other Operating Cash Flow
Cash from Operating Activities9.214.4831.411.448.9
Capital Expenditures-180-41-18.3-16-6.55
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items99.86.1769.60.0150.771
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-80.7-34.951.3-15.9-5.78
Financing Cash Flow Items-6.89-3.52-15.8-11.8-10.6
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities18.822-71.120.5-44
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-52.8-8.5511.815.4-0.984

Or unlock with your email

Or unlock with your email